US Stock MarketDetailed Quotes

PBLA Panbela Therapeutics

Watchlist
  • 0.440
  • -0.040-8.31%
15min DelayClose May 17 16:00 ET
2.14MMarket Cap0.01P/E (TTM)

Panbela Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
3.68%-9.39M
-65.29%-25.25M
38.44%-3.08M
-319.15%-6.68M
-36.79%-5.74M
-117.51%-9.75M
-110.85%-15.28M
-124.55%-5M
-17.22%-1.59M
-147.90%-4.2M
Net income from continuing operations
-39.25%-7.12M
27.68%-25.26M
-36.73%-6.47M
-78.03%-7.84M
73.62%-5.84M
-39.47%-5.11M
-244.68%-34.93M
-33.83%-4.74M
-104.36%-4.4M
-912.35%-22.13M
Operating gains losses
----
---400K
----
----
----
----
----
----
----
----
Other non cash items
-19.05%34K
-12.82%238K
164.77%466K
-498.81%-335K
--65K
--42K
--273K
--176K
--84K
----
Change In working capital
50.43%-2.41M
-215.74%-647K
574.67%3.2M
-47.70%1.31M
-169.09%-296K
-322.24%-4.86M
-65.13%559K
-169.30%-675K
442.39%2.5M
-185.27%-110K
-Change in receivables
---140K
-162.26%-132K
77.78%-20K
-88.96%37K
---149K
--0
315.69%212K
-135.71%-90K
570.00%335K
--0
-Change in prepaid assets
56.74%-912K
-100.74%-5.4M
-124.18%-5.02M
1,214.66%2.59M
-135.34%-859K
20.45%-2.11M
-817.41%-2.69M
-335.21%-2.24M
-354.95%-232K
8,003.33%2.43M
-Change in payables and accrued expense
-150.46%-1.36M
60.82%4.88M
396.81%2.7M
-155.10%-1.32M
3,960.00%812K
75.52%2.69M
64.50%3.04M
-173.54%-909K
649.84%2.39M
-91.56%20K
-Change in other current assets
--0
----
----
--0
---100K
---5.44M
----
----
--0
----
Cash from discontinued investing activities
Operating cash flow
3.68%-9.39M
-65.29%-25.25M
38.44%-3.08M
-319.15%-6.68M
-36.79%-5.74M
-117.51%-9.75M
-110.85%-15.28M
-124.55%-5M
-17.22%-1.59M
-147.90%-4.2M
Investing cash flow
Cash flow from continuing investing activities
160.98%400K
0
40,100.00%400K
-656K
0
-1K
Net intangibles purchase and sale
----
160.61%400K
--0
40,100.00%400K
----
----
---660K
--0
---1K
----
Net business purchase and sale
----
--0
--0
--0
----
----
--4K
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
----
160.98%400K
--0
40,100.00%400K
----
----
---656K
--0
---1K
----
Financing cash flow
Cash flow from continuing financing activities
-48.32%7.08M
388.27%26.14M
-11.22%4.75M
-480.00%-19K
7.71M
13.7M
-46.97%5.35M
534,800.00%5.35M
-99.94%5K
0
Net issuance payments of debt
39.39%-1M
---1.65M
--0
--0
--0
---1.65M
--0
--0
--0
--0
Net common stock issuance
-47.36%8.08M
330.79%23.04M
-100.17%-9K
---19K
--7.72M
--15.35M
-40.92%5.35M
534,800.00%5.35M
--0
--0
Proceeds from stock option exercised by employees
----
94,880.00%4.75M
--4.75M
----
----
----
-99.52%5K
--0
----
----
Net other financing activities
----
----
----
--0
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-48.32%7.08M
388.27%26.14M
-11.22%4.75M
-480.00%-19K
--7.71M
--13.7M
-46.97%5.35M
534,800.00%5.35M
-99.94%5K
--0
Net cash flow
Beginning cash position
100.62%2.58M
-89.17%1.29M
-3.61%907K
184.78%7.21M
-29.12%5.24M
-89.17%1.29M
31.53%11.87M
-93.31%941K
-60.50%2.53M
-8.79%7.39M
Current changes in cash
-158.44%-2.31M
112.22%1.29M
382.37%1.67M
-296.22%-6.3M
140.54%1.97M
188.18%3.95M
-471.03%-10.58M
115.54%346K
-120.65%-1.59M
-186.59%-4.85M
Effect of exchange rate changes
-100.00%-6K
--0
200.00%2K
---2K
175.00%3K
-250.00%-3K
33.33%-4K
-109.09%-2K
--0
---4K
End cash Position
-95.00%262K
100.62%2.58M
100.62%2.58M
-3.61%907K
184.78%7.21M
-29.12%5.24M
-89.17%1.29M
-89.17%1.29M
-93.31%941K
-60.50%2.53M
Free cash flow
3.68%-9.39M
-58.44%-25.25M
38.44%-3.08M
-318.88%-6.68M
-18.22%-5.74M
-117.51%-9.75M
-119.96%-15.94M
-124.55%-5M
-17.29%-1.59M
-186.83%-4.86M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 3.68%-9.39M-65.29%-25.25M38.44%-3.08M-319.15%-6.68M-36.79%-5.74M-117.51%-9.75M-110.85%-15.28M-124.55%-5M-17.22%-1.59M-147.90%-4.2M
Net income from continuing operations -39.25%-7.12M27.68%-25.26M-36.73%-6.47M-78.03%-7.84M73.62%-5.84M-39.47%-5.11M-244.68%-34.93M-33.83%-4.74M-104.36%-4.4M-912.35%-22.13M
Operating gains losses -------400K--------------------------------
Other non cash items -19.05%34K-12.82%238K164.77%466K-498.81%-335K--65K--42K--273K--176K--84K----
Change In working capital 50.43%-2.41M-215.74%-647K574.67%3.2M-47.70%1.31M-169.09%-296K-322.24%-4.86M-65.13%559K-169.30%-675K442.39%2.5M-185.27%-110K
-Change in receivables ---140K-162.26%-132K77.78%-20K-88.96%37K---149K--0315.69%212K-135.71%-90K570.00%335K--0
-Change in prepaid assets 56.74%-912K-100.74%-5.4M-124.18%-5.02M1,214.66%2.59M-135.34%-859K20.45%-2.11M-817.41%-2.69M-335.21%-2.24M-354.95%-232K8,003.33%2.43M
-Change in payables and accrued expense -150.46%-1.36M60.82%4.88M396.81%2.7M-155.10%-1.32M3,960.00%812K75.52%2.69M64.50%3.04M-173.54%-909K649.84%2.39M-91.56%20K
-Change in other current assets --0----------0---100K---5.44M----------0----
Cash from discontinued investing activities
Operating cash flow 3.68%-9.39M-65.29%-25.25M38.44%-3.08M-319.15%-6.68M-36.79%-5.74M-117.51%-9.75M-110.85%-15.28M-124.55%-5M-17.22%-1.59M-147.90%-4.2M
Investing cash flow
Cash flow from continuing investing activities 160.98%400K040,100.00%400K-656K0-1K
Net intangibles purchase and sale ----160.61%400K--040,100.00%400K-----------660K--0---1K----
Net business purchase and sale ------0--0--0----------4K--0--0----
Cash from discontinued investing activities
Investing cash flow ----160.98%400K--040,100.00%400K-----------656K--0---1K----
Financing cash flow
Cash flow from continuing financing activities -48.32%7.08M388.27%26.14M-11.22%4.75M-480.00%-19K7.71M13.7M-46.97%5.35M534,800.00%5.35M-99.94%5K0
Net issuance payments of debt 39.39%-1M---1.65M--0--0--0---1.65M--0--0--0--0
Net common stock issuance -47.36%8.08M330.79%23.04M-100.17%-9K---19K--7.72M--15.35M-40.92%5.35M534,800.00%5.35M--0--0
Proceeds from stock option exercised by employees ----94,880.00%4.75M--4.75M-------------99.52%5K--0--------
Net other financing activities --------------0------------------------
Cash from discontinued financing activities
Financing cash flow -48.32%7.08M388.27%26.14M-11.22%4.75M-480.00%-19K--7.71M--13.7M-46.97%5.35M534,800.00%5.35M-99.94%5K--0
Net cash flow
Beginning cash position 100.62%2.58M-89.17%1.29M-3.61%907K184.78%7.21M-29.12%5.24M-89.17%1.29M31.53%11.87M-93.31%941K-60.50%2.53M-8.79%7.39M
Current changes in cash -158.44%-2.31M112.22%1.29M382.37%1.67M-296.22%-6.3M140.54%1.97M188.18%3.95M-471.03%-10.58M115.54%346K-120.65%-1.59M-186.59%-4.85M
Effect of exchange rate changes -100.00%-6K--0200.00%2K---2K175.00%3K-250.00%-3K33.33%-4K-109.09%-2K--0---4K
End cash Position -95.00%262K100.62%2.58M100.62%2.58M-3.61%907K184.78%7.21M-29.12%5.24M-89.17%1.29M-89.17%1.29M-93.31%941K-60.50%2.53M
Free cash flow 3.68%-9.39M-58.44%-25.25M38.44%-3.08M-318.88%-6.68M-18.22%-5.74M-117.51%-9.75M-119.96%-15.94M-124.55%-5M-17.29%-1.59M-186.83%-4.86M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg